Q4 2022 Holdings
Filed 2023-02-14 | 3 holdings | $195.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $91.8M | 2,346,934 | 46.9% |
| Lyell Immunopharma Inc | COM | 55083R104 | $70.0M | 20,162,332 | 35.7% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $34.1M | 1,835,876 | 17.4% |